Search
Search
Proteintech
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Immunogen sequence: GETLLHIAS IKGDIPSVEY LLQNGSDPNV KDHAGWTPLH EACNHGHLKV VELLLQHKAL VNTTGYQNDS PLHDAAKNGH VDIVKLLLSY GASRNAVNIF GLRPVDYTDD ESMKSLLLLP EKNESSSASH CSVMNTGQRR DGPLVLIGSG LSSEQQKMLS ELAVILKAKK YTEFDSTVTH VVVPGDAVQS TLKCMLGILN GCWILKFEWV KACLRRKVCE QEEKYEIPEG PRRSRLNREQ LLPKLFDGCY FYLWGTFKHH PKDNLIKLVT AGGGQILSRK PKPDSDVTQT INTVAYHARP DSDQRFCTQY IIYEDLCNYH PERVRQGKVW KAPSSWFIDC VMSFELLPLD S (428-777 aa encoded by BC126426)
This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: BARD 1; BARD-1; BRCA1-associated RING domain gene 1; BRCA1-associated RING domain protein 1; RING-type E3 ubiquitin transferase BARD1
基因别名: BARD1
UniProt ID: (Human) Q99728
Entrez Gene ID: (Human) 580